Expert Commentary
Expert Commentary
Do women treated with ceftriaxone and doxycycline for PID benefit from added metronidazole to broaden anaerobic coverage?
Yes, results from a randomized trial noted a therapeutic benefit in women with pelvic inflammatory disease (PID) who were...
Expert Commentary
COVID-19 and pregnancy: Is miscarriage a risk?
Expert Commentary
Learning to live with COVID-19: Postpandemic life will be reflected in how effectively we leverage this crisis
Four strategies can help us navigate through the COVID-19 health emergency, and lessons learned can guide thinking on future...
Expert Commentary
Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...
Expert Commentary
In the management of cesarean scar defects, is there a superior surgical method for treatment?
According to this meta-analysis, which compared the data on laparoscopic, hysteroscopic, vaginal, and combined laparoscopic and...
Expert Commentary
Daily calorie intake requirements during pregnancy: Does one size fit all?
Women with obesity can maintain their daily calorie intake during pregnancy, according to the results of a...
Expert Commentary
The IUD string check: Benefit or burden?
Routine office visits and patient self-checks for IUD strings are unsupported by data and are costly—it is time to discontinue them
From the Editor
What is the role of the ObGyn in preventing and treating obesity?
As frontline clinicians, obstetrician-gynecologists play an important role in identifying and treating obesity. For overweight...
Expert Commentary
June Medical Services v. Russo: Understanding this high-stakes abortion case
ADVOCACY COLUMN
The main question in this case has been decided before, but with a different Supreme Court. The current...
From the Editor
Progestin-only systemic hormone therapy for menopausal hot flashes
Clinicians treating postmenopausal hot flashes often recommend “systemic estrogen treatment.” However, progestin-only therapy also can effectively...
Expert Commentary
Breast cancer chemoprophylaxis in high-risk women: How persistent is the impact of an aromatase inhibitor after 5 years of use?
Among postmenopausal women at high risk for breast cancer, those treated with anastrozole (N = 1,920) compared with placebo (N = 1,944)...